Expert Pitch

‘Genetic Shield’ May Explain Lower COVID Mortality in Southern Italy Compared to North

Sbarro Health Research Organization (SHRO)

“A 'genetic shield' may have protected southern Italy from the Sars-CoV-2 tsunami that swept the northern regions,” says Antonio Giordano, M.D., Ph.D., Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, and Professor of Pathology at the University of Siena, Italy. “The hypothesis needs to be studied before drawing conclusions, but there is already a solid scientific basis for this theory," Giordano says. 

"There may be a form of defense printed in the DNA against the more serious effects of the coronavirus,” says Giordano, “which seems more widespread in the South of Italy than in the North."

Giordano and his collaborators are currently studying the correlation of certain genetic markers, known as Human Leukocyte Antigen (HLA), to incidence of severe cases of COVID-19 throughout Italy. They have published an article in the journal Frontiers in Immunology, describing their findings and subject for further research. 

Co-Authors Pierpaolo Correale from Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria along with Francesca Pentimalli, of the National Cancer Institute ‘Pascale,” and Patrizia Maiorano, of the University of Siena, suggest that specific variants of HLA genes could underlie susceptibility to the SARS-CoV-2 coronavirus, or predict a worse disease outcome, and the absence of these variants may protect the patient from more severe disease progression.  

“The identification of such immunogenetic determinants would be crucial to inform priorities in future vaccination campaigns, to decide clinical management strategies, and to isolate genetically at risk individuals, including healthcare workers,” says co-author Luciano Mutti, MD, Oncologist and Professor at the Sbarro Institute.

About the Sbarro Health Research Organization
The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org




Filters close

Showing results

1120 of 2776
Released: 3-Aug-2020 9:00 AM EDT
Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19
Neutrolis

Novel Chromatinase™ platform could rapidly and systemically removes NETs associated with exacerbation of COVID-19

Released: 3-Aug-2020 8:55 AM EDT
American College of Radiology to Provide Image Coordination for National COVID-19 Observational Study
American College of Radiology (ACR)

The American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) will serve as the imaging coordination center for the multicenter COVID-19 Observational Study (CORAL) led by Dr. Catherine "Terri" L. Hough of the Oregon Health & Science University. The CORAL Study is part of the Prevention & Early Treatment of Acute Lung Injury (PETAL) Network, a consortium of academic and affiliated hospitals across the United States – funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health – to conduct clinical trials in patients with or at risk for critical illness, including acute respiratory distress syndrome.

Released: 3-Aug-2020 8:35 AM EDT
Evaluating the effectiveness of travel bans
International Institute for Applied Systems Analysis

A new study sheds light on how COVID-19 spreads regionally and between countries, as well as on how effective governmental measures to curb the spread of the pandemic have been to date.

Newswise: Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Released: 3-Aug-2020 8:00 AM EDT
Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Iowa State University

Engineers are developing a no-touch, mail-in, fast-scan diagnostic sensing system that could be used to quickly test for COVID-19 or other outbreaks. The system would also produce a real-time outbreak map with demographic details.

Newswise: Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
30-Jul-2020 1:55 PM EDT
Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
American Association of Critical-Care Nurses (AACN)

Atrium Health’s tele-ICU quickly adjusted its patient-centered focus to include supporting and protecting bedside nurses caring for patients in isolation, as part of the system’s planning and preparations for the pandemic.

Released: 31-Jul-2020 5:05 PM EDT
Looking up to the Joneses: Consequences of the perceptions of white wealth
Society for Personality and Social Psychology

Before the era of COVID-19, research suggested that premature deaths among white Americans were rising. Even before the era of COVID-19, these findings were surprising.

Newswise: 238996_web.jpg
Released: 31-Jul-2020 4:55 PM EDT
Pooling strategy in the wake of the COVID-19 pandemic: A solution for mass population screening of SARS-CoV-2
Elsevier

In a report in the Journal of Molecular Diagnostics, published by Elsevier, researchers at Augusta University and PerkinElmer Genomics describe a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples.

Released: 31-Jul-2020 4:40 PM EDT
No racial disparities seen in response to remdesivir treatment of COVID-19
University of Chicago Medical Center

A new analysis by University of Chicago Medicine faculty, staff and collaborators around the world found remdesivir appears to be equally beneficial to patients regardless of race, supporting the need for early intervention and aggressive care for all patients in the fight against COVID-19.

Released: 31-Jul-2020 3:50 PM EDT
SARS-CoV-2 screening strategies for safe reopening of college campuses
JAMA - Journal of the American Medical Association

What The Study Did: This study defines the screening performance standards for SARS-CoV-2 tests that would permit the safe return of students to U.S. residential college campuses this fall. Authors: A. David Paltiel, Ph.D., of the Yale School of Public Health in New Haven, Connecticut, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.16818) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. ### Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/1

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2020 11:00 AM EDT Released to reporters: 31-Jul-2020 3:15 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

1120 of 2776

close
0.954